These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 12442811)
21. Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents. Mohammad RM; al-Katib A; Pettit GR; Sensenbrenner LL Cancer Res; 1994 Jan; 54(1):165-8. PubMed ID: 8261437 [TBL] [Abstract][Full Text] [Related]
22. [Therapy of Waldenström´s macroglobulinaemia in the year 2014]. Adam Z; Krejčí M; Pour L; Ševčíková E Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419 [TBL] [Abstract][Full Text] [Related]
23. Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia. Paludo J; Abeykoon JP; Kumar S; Shreders A; Ailawadhi S; Gertz MA; Kourelis T; King RL; Reeder CB; Leung N; Kyle RA; Buadi FK; Habermann TM; Dingli D; Witzig TE; Dispenzieri A; Lacy MQ; Go RS; Lin Y; Gonsalves WI; Warsame R; Lust JA; Rajkumar SV; Ansell SM; Kapoor P Br J Haematol; 2017 Oct; 179(1):98-105. PubMed ID: 28786474 [TBL] [Abstract][Full Text] [Related]
25. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience]. Adam Z; Pour L; Krejčí M; Ševčíková S; Pourová E; Ševčíková E; Král Z; Mayer J Vnitr Lek; 2016 Jan; 62(1):25-39. PubMed ID: 26967234 [TBL] [Abstract][Full Text] [Related]
31. Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study. Kersten MJ; Amaador K; Minnema MC; Vos JMI; Nasserinejad K; Kap M; Kastritis E; Gavriatopoulou M; Kraan W; Chamuleau MED; Deeren D; Tick LW; Doorduijn JK; Offner F; Böhmer LH; Liu RD; Pals ST; Dimopoulos MA J Clin Oncol; 2022 Jan; 40(1):40-51. PubMed ID: 34388022 [TBL] [Abstract][Full Text] [Related]
32. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab. Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256 [TBL] [Abstract][Full Text] [Related]
33. A SCID-hu in vivo model of human Waldenström macroglobulinemia. Tassone P; Neri P; Kutok JL; Tournilhac O; Santos DD; Hatjiharissi E; Munshi V; Venuta S; Anderson KC; Treon SP; Munshi NC Blood; 2005 Aug; 106(4):1341-5. PubMed ID: 15886318 [TBL] [Abstract][Full Text] [Related]
34. Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenström's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation. Kawano N; Ikeda N; Yoshida S; Sugio Y; Yamashita K; Uezono S; Hayashi T; Hara S; Makino S; Shimoda K; Ueda A Int J Hematol; 2010 Sep; 92(2):391-7. PubMed ID: 20686877 [TBL] [Abstract][Full Text] [Related]
35. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia. Weber DM; Dimopoulos MA; Delasalle K; Rankin K; Gavino M; Alexanian R Semin Oncol; 2003 Apr; 30(2):243-7. PubMed ID: 12720145 [TBL] [Abstract][Full Text] [Related]